Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
Article
[키워드] acute respiratory syndrome
Administered
advanced age
Analysis
Anti-CD20 antibody
chronic
chronic lymphocytic leukemia
clinical experience
CLL
CLL patient
Concentration
coronavirus
Course
COVID-19
COVID-19 patient
death
died
elevated lactate dehydrogenase
Factor
Hematological malignancy
hemoglobin
Hospitalization
increased risk
Infection
inhibitor
leukemia
naïve
outcome
Patient
performance status
performed
Platelet
Prognosis
required
Retrospective study
risk of death
SARS-CoV-2
SARS-COV-2 infection
significantly shorter
simple
survival
the SARS-CoV-2
therapy
treated
Treatment
tyrosine
venetoclax
with COVID-19
worldwide pandemic
[DOI] 10.3390/cancers14030558 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/cancers14030558 PMC 바로가기 [Article Type] Article